Persistent Depressive Disorder Quality Control & Assurance 3 — Questions and Answers
Question 1: What is the purpose of conducting a differential diagnosis review as part of PDD quality assurance?
- To increase the number of diagnoses given
- To ensure conditions like MDD, bipolar disorder, and medical causes have been appropriately ruled out (Correct answer)
- To reduce documentation burden
- To limit referrals to specialists
Correct answer: To ensure conditions like MDD, bipolar disorder, and medical causes have been appropriately ruled out
Quality care requires ruling out MDD, bipolar disorder, hypothyroidism, and other causes before confirming a PDD diagnosis.
Question 2: A QA review reveals clinicians are diagnosing PDD without screening for past manic episodes. What is the clinical risk?
- PDD patients never have manic episodes
- Undetected bipolar disorder may lead to inappropriate antidepressant monotherapy (Correct answer)
- Mania screening is only required in inpatient settings
- This is a documentation issue with no clinical consequence
Correct answer: Undetected bipolar disorder may lead to inappropriate antidepressant monotherapy
Antidepressant monotherapy in undiagnosed bipolar disorder can precipitate mania, making bipolar screening a patient safety requirement.
Question 3: Which of the following is a standard quality benchmark for suicide risk assessment in PDD patients?
- Suicide risk is assessed only at intake
- Risk assessment is completed at every visit using a validated tool (Correct answer)
- Only patients with prior attempts require risk screening
- Risk assessment is deferred to psychiatrists only
Correct answer: Risk assessment is completed at every visit using a validated tool
Ongoing suicide risk assessment at every visit is a quality standard because chronic depression elevates sustained suicide risk.
Question 4: A quality improvement team finds high variability in PDD diagnosis across clinicians in a practice. What intervention best addresses this?
- Requiring longer sessions
- Standardizing diagnostic protocols using DSM-5 criteria checklists and structured interviews (Correct answer)
- Reducing caseloads
- Eliminating group supervision
Correct answer: Standardizing diagnostic protocols using DSM-5 criteria checklists and structured interviews
Standardizing diagnostic protocols with structured tools reduces inter-clinician variability and improves diagnostic reliability.
Question 5: Under quality care standards, how should comorbid anxiety be managed in a patient diagnosed with PDD?
- Treat PDD only; anxiety resolves on its own
- Ignore anxiety until PDD is in full remission
- Identify and treat comorbid anxiety as part of the integrated treatment plan (Correct answer)
- Refer anxiety treatment to a separate provider with no coordination
Correct answer: Identify and treat comorbid anxiety as part of the integrated treatment plan
Comorbid anxiety is common in PDD and should be integrated into the treatment plan because it worsens outcomes if untreated.
Question 6: What does a treatment fidelity check in a PDD-focused CBT program primarily assess?
- Therapist billing accuracy
- Whether therapists are delivering CBT components as intended by the manualized protocol (Correct answer)
- Patient attendance rates only
- Office cleanliness and session scheduling
Correct answer: Whether therapists are delivering CBT components as intended by the manualized protocol
Fidelity checks verify that therapists are correctly delivering the therapeutic components as specified in the evidence-based protocol.
Question 7: Which documentation element is most critical for quality assurance when a patient with PDD refuses recommended medication?
- No documentation is needed if the patient refuses
- Document refusal, risks discussed, alternatives offered, and patient's autonomous decision (Correct answer)
- Only note the refusal in the medication log
- Discharge the patient immediately
Correct answer: Document refusal, risks discussed, alternatives offered, and patient's autonomous decision
Comprehensive documentation of informed refusal protects the patient's autonomy and the clinician's accountability within quality standards.
Persistent Depressive Disorder Quality Control & Assurance 3
What is the purpose of conducting a differential diagnosis review as part of PDD quality assurance?